Status:
COMPLETED
Appropriate Medication Use in Dutch Terminal Care
Lead Sponsor:
Prof.dr Carin (C.C.D.) van der Rijt
Collaborating Sponsors:
Rijnstate Hospital
Ikazia Hospital, Rotterdam
Conditions:
Palliative Care
Terminal Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The AMUSE trial is a multicentre stepped-wedge cluster randomized controlled trial where medication optimization of patients with a life expectancy of less than three months is investigated by using C...
Detailed Description
Rationale: patients in the last phase of life often use many medications that are continued until shortly before they die. This is partly inevitable, because these patients often experience multiple d...
Eligibility Criteria
Inclusion
- Patient is 18 years or older and provides informed consent to participate.
- The patient is aware that recovering from his/her disease is unlikely, to be assessed by the attending physician.
- The patient is competent to decide about trial participation
- The patient has a life expectancy of at least two weeks and at most three months, as estimated by an attending physician.
Exclusion
- The patient is incapable of filling in a questionnaire (patients may be supported by relatives when filling in the questionnaire).
Key Trial Info
Start Date :
April 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05351281
Start Date
April 29 2022
End Date
February 20 2025
Last Update
March 21 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Noordwest Ziekenhuisgroep
Alkmaar, Netherlands
2
Rijnstate Hospital
Arnhem, Netherlands
3
Gezondheidscentrum Krimpen
Krimpen aan den IJssel, Netherlands
4
Nijmegen University Academic Network Family Medicine
Nijmegen, Netherlands